MAPT and early-onset autosomal dominant Alzheimer disease: Also, the BDNF-Met allele is associated with increased levels of biomarkers such as tau and phospho-tau and poorer cognitive performance in non-symptomatic as well as in symptomatic dominantly inherited Alzheimer’s disease [24].